P55072 (TERA_HUMAN) Homo sapiens (Human)
Transitional endoplasmic reticulum ATPase UniProtKBInterProSTRINGInteractive Modelling
806 aa; Sequence (Fasta) ;
42 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
125 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and polyubiquitinated Ub-Eos (FOM, Class 2) |
Heteromer | 99.73 | 5×ADP; 7×ATP; 7×MG; | |||
| Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and polyubiquitinated Ub-Eos (FOM, Class 3) |
Heteromer | 99.73 | 4×ADP; 8×ATP; 8×MG; | |||
| Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and polyubiquitinated Ub-Eos (CHAPSO, Clas… |
Heteromer | 99.73 | 5×ADP; 7×ATP; 7×MG; | |||
| Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and polyubiquitinated Ub-Eos (FOM, Class 1) |
Heteromer | 99.73 | 5×ADP; 7×ATP; 7×MG; | |||
| Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and polyubiquitinated Ub-Eos (CHAPSO, Clas… |
Heteromer | 99.73 | 5×ADP; 7×ATP; 7×MG; | |||
| Cryo-EM structure of P97-VCPIP1 complex |
Heteromer Q96JH7; | 100 | ||||
| p47-bound p97-R155H mutant with ATPgammaS |
Heteromer O35987; | 99.86 | 12×AGS; | |||
| p47-bound p97-R155H mutant with ADP |
Heteromer O35987; | 99.86 | 12×ADP; | |||
| The cryo-EM structure of human ERAD retro-translocation complex |
Heteromer Q9BUN8; | 100 | 6×ATP; 6×ADP; | |||
| The cryo-EM structure of human ERAD retro-translocation complex |
Heteromer Q9BUN8; | 100 | 4×ADP; | |||
| The cryo-EM structure of human ERAD retro-translocation complex |
Heteromer Q9BUN8; | 100 | 12×ADP; | |||
| p97 variant 2 in the apo state |
Heteromer | 99.45 | 12×SO4; | |||
| p97-p37-SPI substrate complex |
Heteromer P36873; Q14CS0; Q15435; | 100 | ||||
| p97-delta709-728 in complex with a UFD1-SHP peptide |
Heteromer Q92890; | 100.0 | 12×AGS; 12×MG; 6×CL; 2×GOL; | |||
| Quantitative interaction mapping reveals an extended ubiquitin regulatory domain in ASPL that disru… |
Heteromer Q9BZE9; | 100.0 | 4×ADP; | |||
| Cryo-EM structure of p97:UBXD1 meta state |
Heteromer Q9BZV1; | 100.0 | 12×ADP; | |||
| Cryo-EM structure of p97:UBXD1 PUB-in state |
Heteromer Q9BZV1; | 100.0 | 12×ADP; | |||
| Cryo-EM structure of p97:UBXD1 para state |
Heteromer Q9BZV1; | 100.0 | 12×ADP; | |||
| Cryo-EM structure of p97:UBXD1 open state |
Heteromer Q9BZV1; | 100.0 | 12×ADP; | |||
| Cryo-EM structure of p97:UBXD1 closed state |
Heteromer Q9BZV1; | 100.0 | 12×ADP; | |||
| Cryo-EM structure of p97:UBXD1 VIM-only state |
Heteromer Q9BZV1; | 100.0 | 12×ADP; | |||
| Cryo-EM structure of p97:UBXD1 lariat mutant |
Heteromer Q9BZV1; | 100.0 | 12×ADP; | |||
| Cryo-EM structure of p97:UBXD1 H4-bound state |
Heteromer Q9BZV1; | 100.0 | 12×ADP; | |||
| Structure of human p97 ATPase L464P mutant |
Heteromer | 99.86 | 6×ADP; | |||
| Structure of p97 (subunits A to E) with substrate engaged |
Heteromer | 100.0 | 10×ADP; 8×BEF; 8×MG; | |||
| Quantitative interaction mapping reveals an extended ubiquitin regulatory domain in ASPL that disru… |
Heteromer Q9BZE9; | 100.0 | 2×ADP; 2×MG; 1×SO4; 3×EDO; 1×GOL; | |||
| p97 ND1-A232E in complex with VIMP |
Heteromer Q9BQE4; | 99.78 | 6×ANP; 6×MG; | |||
| p97 ND1-L198W in complex with VIMP |
Heteromer Q9BQE4; | 99.77 | 2×ANP; 2×MG; | |||
| Crystal structure of AAA ATPase p97/VCP ND1 in complex with p47 C |
Heteromer O35987; Q01853; | 99.77 | 6×ADP; | |||
| Common mode of remodeling AAA ATPases p97/CDC48 by their disassembly cofactors ASPL/PUX1 |
Heteromer Q9LK22; | 100 | 6×ADP; | |||
| Structural basis for targeted p97 remodelling by ASPL as prerequisite for p97 trimethylation by MET… |
Heteromer Q9BZE9; Q9H867; | 100.0 | 4×EDO; 1×ATP; 1×MG; 1×SAH; | |||
| Crystal structure of p97-N/D1 hexamer in complex with FAF1-UBX domain |
Heteromer Q9UNN5; | 99.31 | 12×ADP; | |||
| Crystal structure of the p97-N/D1 hexamer in complex with six p47-UBX domains |
Heteromer Q9UNZ2; | 99.54 | 12×ADP; | |||
| Crystal structure of p97 N/D1 in complex with a valosin-containing protein methyltransferase |
Heteromer Q9H867; | 100.0 | 1×SAH; 3×GOL; 2×FMT; 1×ACT; 1×ADP; 1×EPE; | |||
| Strctural Model of the p97 N domain- npl4 UBD complex |
Heteromer P60670; Q01853; | 99.48 | ||||
| Crystal structure of p97-N in complex with FAF1-UBX |
Heteromer Q9UNN5; | 100 | 1×CL; | |||
| Crystal structure of FAF1 UBX-p97N-domain complex |
Heteromer Q9UNN5; | 100 | ||||
| Crystal structure of p97/VCP N in complex with OTU1 UBXL |
Heteromer P43558; | 100 | ||||
| Structural Details of Ufd1 binding to p97 |
Heteromer Q92890; | 100 | ||||
| Structural Insights into the Interaction of p97 N-terminus Domain and VBM Motif in Rhomboid Proteas… |
Heteromer Q8TEB9; | 100 | ||||
| Crystal Structure of FAF1 UBX Domain In Complex with p97/VCP N Domain Reveals The Conserved FcisP T… |
Heteromer Q9UNN5; | 100 | ||||
| Structural insights into the interaction of p97 N-terminal domain and SHP motif in Derlin-1 rhomboi… |
Heteromer Q9BUN8; | 100 | ||||
| Crystal structure of the UBX domain of human UBXD7 in complex with p97 N domain |
Heteromer O94888; | 100 | ||||
| Crystal structure of p97N in complex with the C-terminus of gp78 |
Heteromer Q9UKV5; | 100.0 | 2×CL; | |||
| Crystal structure of p97/VCP N in complex with OTU1 UBXL |
Heteromer P43558; | 100.0 | ||||
| PLAP/P97 complex |
Heteromer Q9Y263; | 100 | 1×MG; | |||
| Crystal structure of HOIP PUB domain in complex with p97 PIM |
Heteromer Q96EP0; | 100 | ||||
| Human p97 double hexamer conformer II with ATPgammaS bound | homo-12-mer | 100 | 24×AGS; 12×MG; | |||
| Human p97 double hexamer conformer I with D1-ATPgammaS and D2-ADP bound | homo-12-mer | 100 | 12×AGS; 12×MG; 12×ADP; | |||
| Cryo-EM structure of human p97 bound to CB-5083 and ADP. | homo-12-mer | 100.0 | 12×JDP; 12×ADP; | |||
| Cryo-EM structure of dodecamer P97 | homo-12-mer | 100 | 12×ADP; 12×Y6Y; | |||
| Structure of VCP dodecamer purified from H1299 cells | homo-12-mer | 100.0 | ||||
| Structure of apo VCP dodecamer generated from bacterially recombinant VCP/p97 | homo-12-mer | 99.86 | ||||
| Human p97/VCP structure with a triazole inhibitor (NSC799462/dodecamer) | homo-12-mer | 100.0 | 24×ADP; 12×XKM; | |||
| Cryo-EM structure of human p97 bound to CB-5083 and ATPgS. | homo-12-mer | 100.0 | 12×AGS; 12×MG; 12×JDP; | |||
| p97-R155H mutant dodecamer I | homo-12-mer | 100.0 | ||||
| p97-R155H mutant dodecamer II | homo-12-mer | 100.0 | ||||
| p97 D1D2 with CB5083 bound | homo-12-mer | 100.0 | 12×JDP; | |||
| Structure of VCP in complex with an ATPase activator (D2 domains only, dodecameric form) | homo-12-mer | 100.0 | 12×A1AC1; | |||
| Structure of D2 subdomain of P97/VCP in complex with ADP | homo-7-mer | 100.0 | 7×ADP; | |||
| Cryo-EM structure of human p97 in complex with NMS-873 in the presence of ATP, Npl4/Ufd1, and Ub6 | homo-6-mer | 99.73 | 12×ATP; 6×Y6Y; 12×MG; | |||
| Cryo-EM structure of human p97-R191Q mutant bound to ADP. | homo-6-mer | 99.87 | 12×ADP; | |||
| Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and Ub6 (Class 2) | homo-6-mer | 99.73 | 4×ADP; 8×ATP; 7×MG; | |||
| Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and Ub6 (Class 1) | homo-6-mer | 99.73 | 4×ADP; 8×ATP; 8×MG; | |||
| Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and Ub6 (Class 3) | homo-6-mer | 99.73 | 5×ADP; 7×ATP; 7×MG; | |||
| Human p97 single hexamer conformer I with ATPgammaS bound | homo-6-mer | 100 | 12×AGS; 12×MG; | |||
| Cryo-EM structure of human p97-R191Q mutant bound to ATPgS. | homo-6-mer | 99.86 | 12×AGS; 12×MG; | |||
| Cryo-EM structure of human p97-R155H mutant bound to ATPgS. | homo-6-mer | 99.86 | 12×AGS; 12×MG; | |||
| Cryo-EM structure of human p97-A232E mutant bound to ATPgS. | homo-6-mer | 99.86 | 12×AGS; 12×MG; | |||
| Structure of human p97 in complex with ATPgammaS and Npl4/Ufd1 (masked around p97) | homo-6-mer | 100.0 | 12×MG; 12×AGS; | |||
| Cryo-EM structure of human p97 bound to ATPgS (Conformation III) | homo-6-mer | 100.0 | 12×AGS; 12×MG; | |||
| Cryo-EM structure of human p97-D592N mutant bound to ADP. | homo-6-mer | 99.86 | 12×ADP; | |||
| Cryo-EM structure of human p97-R155H mutant bound to ADP. | homo-6-mer | 99.86 | 12×ADP; | |||
| Cryo-EM structure of human p97-A232E mutant bound to ADP | homo-6-mer | 99.86 | 12×ADP; | |||
| Cryo-EM structure of human p97-E470D mutant bound to ADP. | homo-6-mer | 99.86 | 12×ADP; | |||
| p97 (VCP) mutant - F266A | homo-6-mer | 99.87 | ||||
| Structure of apo VCP hexamer generated from bacterially recombinant VCP/p97 | homo-6-mer | 99.86 | ||||
| Human p97/VCP structure with a triazole inhibitor (NSC799462/hexamer) | homo-6-mer | 100.0 | 12×ADP; 6×XKM; | |||
| Full composite cryo-EM map of p97/VCP in ADP.Pi state | homo-6-mer | 100.0 | 6×ADP; 6×ATP; 12×MG; 6×K; 6×PO4; | |||
| p97-delta709-728 in complex with ATP-gamma-S | homo-6-mer | 100.0 | 12×AGS; 12×MG; 6×CL; | |||
| Human p97 single hexamer conformer III with D1-ATPgammaS and D2-ADP bound | homo-6-mer | 100 | 6×AGS; 6×MG; 6×ADP; | |||
| Human p97/VCP R155H mutant structure with a triazole inhibitor (NSC819701/down) | homo-6-mer | 99.87 | 12×ADP; 6×XO8; | |||
| p97-N750D/R753D/M757D/Q760D in complex with ATP-gamma-S | homo-6-mer | 99.46 | 12×AGS; 12×MG; | |||
| Human p97 single hexamer conformer II with ATPgammaS bound | homo-6-mer | 100.0 | 12×AGS; 12×MG; | |||
| Human AAA+ ATPase VCP mutant - T76A, AMP-PNP-bound form, Conformation I | homo-6-mer | 99.86 | 6×ADP; 6×ANP; | |||
| Cryo-EM structure of human p97-D592N mutant bound to ATPgS. | homo-6-mer | 99.86 | 12×AGS; 12×MG; | |||
| Cryo-EM structure of human p97-E470D mutant bound to ATPgS. | homo-6-mer | 99.86 | 12×AGS; 12×MG; | |||
| Cryo-EM structure of human p97 bound to ATPgS (Conformation II) | homo-6-mer | 100.0 | 6×AGS; 6×ADP; 6×MG; | |||
| Human AAA+ ATPase VCP mutant - T76E, ADP-bound form | homo-6-mer | 99.86 | 12×ADP; | |||
| Human AAA+ ATPase VCP mutant - T76A, ADP-bound form | homo-6-mer | 99.86 | 12×ADP; | |||
| Human AAA+ ATPase VCP mutant - T76E, AMP-PNP bound form, Conformation I | homo-6-mer | 99.86 | 6×ADP; 6×ANP; | |||
| p97 (VCP) mutant - F539A | homo-6-mer | 99.87 | 10×ADP; | |||
| p97 (VCP) mutant - F539A state III | homo-6-mer | 99.87 | 1×ATP; 11×ADP; | |||
| Structure of P97/vcp in complex with ADP | homo-6-mer | 100.0 | 12×ADP; | |||
| Structure of P97/vcp in complex with ADP/ADP.alfx | homo-6-mer | 100.0 | 12×ADP; 6×AF3; | |||
| p97 (VCP) double mutant - F266A F539A | homo-6-mer | 99.73 | ||||
| Cryo-EM structure of human p97 bound to UPCDC30245 inhibitor | homo-6-mer | 100.0 | 12×ADP; 6×OJA; | |||
| Cryo-EM structure of human p97 bound to ADP | homo-6-mer | 100.0 | 12×ADP; | |||
| Cryo-EM structure of human p97 bound to ATPgS (Conformation I) | homo-6-mer | 100.0 | 12×ADP; | |||
| p97 (VCP) mutant - F539A ADP state | homo-6-mer | 99.86 | 12×ADP; | |||
| Structure of P97/vcp in complex with ADP/AMP-PNP | homo-6-mer | 100.0 | 6×ADP; 6×ANP; | |||
| The crystal structure of murine p97/VCP at 3.6A | homo-6-mer | 99.85 | 6×ADP; | |||
| Structure of human p97 ATPase L464P mutant | homo-6-mer | 99.81 | 6×ADP; | |||
| Human p97/VCP R155H mutant structure with a triazole inhibitor (NSC819701/up) | homo-6-mer | 100.0 | 12×ADP; 6×XO8; | |||
| D1 and D2 domain structure of the p97(R155H)-p47 complex | homo-6-mer | 100.0 | ||||
| Human p97/VCP R155H mutant structure with a triazole inhibitor (NSC804515) | homo-6-mer | 100.0 | 12×ADP; 6×XNU; | |||
| Structure of p97 N-D1 R155H mutant in complex with ATPgS | homo-6-mer | 99.78 | 6×AGS; 6×MG; | |||
| Structure of p97 N-D1 R155H mutant in complex with ATPgS | homo-6-mer | 99.78 | 6×AGS; 6×MG; | |||
| Structure of p97 N-D1 R86A mutant in complex with ATPgS | homo-6-mer | 99.78 | 6×AGS; 6×MG; | |||
| Structure of p97 N-D1 A232E mutant in complex with ATPgS | homo-6-mer | 99.78 | 6×AGS; 6×MG; | |||
| Structure of p97 N-D1 R95G mutant in complex with ATPgS | homo-6-mer | 99.78 | 6×AGS; 6×MG; | |||
| Structure of p97 N-D1(L198W) in complex with Fragment TROLL2 | homo-6-mer | 99.77 | 6×ADP; 96×FMT; 6×6LY; 6×PEG; 6×NA; | |||
| Structure of p97 N-D1 L198W mutant in complex with ADP | homo-6-mer | 99.78 | 6×ADP; | |||
| Structure of p97 N-D1 R155H mutant in complex with ADP | homo-6-mer | 99.77 | 6×ADP; | |||
| Structure of p97 N-D1 wild-type in complex with ADP | homo-6-mer | 100 | 6×ADP; | |||
| Structure of the N-Terminal domain and the D1 AAA domain of membrane fusion ATPase p97 | homo-6-mer | 99.77 | 6×ADP; | |||
| Structure of VCP in complex with an ATPase activator (D2 domains only, hexameric form) | homo-6-mer | 100.0 | 6×A1AC1; | |||
| Structure of VCP in complex with an ATPase activator and ADP (D2 domains only, hexameric form) | homo-6-mer | 100.0 | 6×ADP; 6×A1AC1; | |||
| Crystal structure of the p97 D2 domain in a helical split-washer conformation | monomer | 100 | 4×MPD; 1×DMS; 1×ADP; | |||
| Crystal structure of the p97 D2 domain in a helical split-washer conformation | monomer | 100.0 | 4×MPD; 2×DMS; 2×EJQ; 1×ADP; 1×NA; | |||
| Crystal structure of the p97 D2 domain in a helical split-washer conformation | monomer | 100.0 | 4×MPD; 2×DMS; 1×ADP; 1×NA; 1×EJW; | |||
| Crystal structure of the p97 D2 domain in a helical split-washer conformation | monomer | 100.0 | 4×MPD; 2×DMS; 1×ADP; 1×NA; 1×ELQ; | |||
| Crystal structure of the p97 D2 domain in a helical split-washer conformation | monomer | 100.0 | 4×MPD; 2×DMS; 1×ADP; 1×NA; 1×ELN; | |||
| Crystal structure of the p97 D2 domain in a helical split-washer conformation | monomer | 100.0 | 4×MPD; 2×DMS; 1×ADP; 1×NA; 1×AWD; | |||
| Crystal Structure of the p97 N-terminal domain | monomer | 100 | 1×HEZ; 1×GOL; 1×CO; 1×CL; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8fcl.1.E | monomer | 0.78 | 1×ADP; | 100.00 | ||
| 3cf2.2.E | homo-6-mer | 0.68 | 6×ADP; 6×ANP; | 100.00 | ||